(Q37554503)

21 August 2017

1 reference

title

Phospho-p70S6K and cdc2/cdk1 as therapeutic targets for diffuse large B-cell lymphoma (English)

1 reference

21 August 2017

Xianfeng Frank Zhao

1

1 reference

PubMed ID

19614561

21 August 2017

Ronald B Gartenhaus

series ordinal

2

1 reference

PubMed ID

19614561

21 August 2017

language of work or name

English

0 references

publication date

1 September 2009

1 reference

Expert Opinion on Therapeutic Targets

21 August 2017

1 reference

21 August 2017

13

1 reference

21 August 2017

9

1 reference

21 August 2017

1085-1093

1 reference

New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project

21 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14728220903103833

Combination sequential chemotherapy in advanced reticulum cell sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903103833

Combination chemotherapy of diffuse histiocytic lymphoma with cyclophosphamide, adriamycin, vincristine and prednisone (CHOP)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903103833

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903103833

Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903103833

Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903103833

The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903103833

Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903103833

The protein kinase B/Akt signalling pathway in human malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903103833

Phospho-p70S6K/p85S6K and cdc2/cdk1 are novel targets for diffuse large B-cell lymphoma combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903103833

Comprehensive copy number and gene expression profiling of the 17q23 amplicon in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903103833

Cloning and expression of two human p70 S6 kinase polypeptides differing only at their amino termini

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903103833

A single gene encodes two isoforms of the p70 S6 kinase: activation upon mitogenic stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903103833

S6 phosphorylation and the p70s6k/p85s6k

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903103833

RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903103833

Regulation of an activated S6 kinase 1 variant reveals a novel mammalian target of rapamycin phosphorylation site

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903103833

The modular phosphorylation and activation of p70s6k.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903103833

Regulation of the p70 S6 kinase by phosphorylation in vivo. Analysis using site-specific anti-phosphopeptide antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903103833

Targeted disruption of p70(s6k) defines its role in protein synthesis and rapamycin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903103833

Oncogenes as molecular targets in lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903103833

PDGF- and insulin-dependent pp70S6k activation mediated by phosphatidylinositol-3-OH kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903103833

Activation of pp70/85 S6 kinases in interleukin-2-responsive lymphoid cells is mediated by phosphatidylinositol 3-kinase and inhibited by cyclic AMP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903103833

A specific product of phosphatidylinositol 3-kinase directly activates the protein kinase Akt through its pleckstrin homology domain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903103833

Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903103833

Control of p70 s6 kinase by kinase activity of FRAP in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903103833

Rapamycin, wortmannin, and the methylxanthine SQ20006 inactivate p70s6k by inducing dephosphorylation of the same subset of sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903103833

Immunopurified mammalian target of rapamycin phosphorylates and activates p70 S6 kinase alpha in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903103833

mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903103833

Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903103833

Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903103833

Role of S6 phosphorylation and S6 kinase in cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903103833

Ribosomal S6 kinase signaling and the control of translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903103833

3-Phosphoinositide-dependent protein kinase 1 (PDK1) phosphorylates and activates the p70 S6 kinase in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903103833

Phosphorylation and activation of p70s6k by PDK1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903103833

Identification of the NIMA family kinases NEK6/7 as regulators of the p70 ribosomal S6 kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903103833

Characterization of phosphatidylinositol 3-kinase-dependent phosphorylation of the hydrophobic motif site Thr(389) in p70 S6 kinase 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903103833

A new role for the p85-phosphatidylinositol 3-kinase regulatory subunit linking FRAP to p70 S6 kinase activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903103833

Interleukin 2 stimulation of p70 S6 kinase activity is inhibited by the immunosuppressant rapamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903103833

Activation of 70-kDa S6 kinase, induced by the cytokines interleukin-3 and erythropoietin and inhibited by rapamycin, is not an absolute requirement for cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903103833

Constitutive activation of p70S6k in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903103833

Constitutive activation of phosphatidyl-inositide 3 kinase contributes to the survival of Hodgkin's lymphoma cells through a mechanism involving Akt kinase and mTOR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903103833

Constitutive activation of Akt contributes to the pathogenesis and survival of mantle cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903103833

Activation of mammalian target of rapamycin signaling pathway contributes to tumor cell survival in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903103833

Syk-dependent mTOR activation in follicular lymphoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903103833

p70S6 kinase signals cell survival as well as growth, inactivating the pro-apoptotic molecule BAD

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903103833

Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903103833

Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903103833

Rapamycin-induced G1 arrest in cycling B-CLL cells is associated with reduced expression of cyclin D3, cyclin E, cyclin A, and survivin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903103833

Rapamycin inhibits cdk4 activation, p 21(WAF1/CIP1) expression and G1-phase progression in transformed mouse fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903103833

A rapamycin derivative (everolimus) controls proliferation through down-regulation of truncated CCAAT enhancer binding protein {beta} and NF-{kappa}B activity in Hodgkin and anaplastic large cell lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903103833

Mammalian target of rapamycin inhibition induces cell cycle arrest in diffuse large B cell lymphoma (DLBCL) cells and sensitises DLBCL cells to rituximab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903103833

Complementation used to clone a human homologue of the fission yeast cell cycle control gene cdc2

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903103833

Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903103833

Cell cycle. Confirmational change.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903103833

Control of the G2/M transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903103833

Ran-independent nuclear import of cyclin B1-Cdc2 by importin beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903103833

Nuclear import of Cdk/cyclin complexes: identification of distinct mechanisms for import of Cdk2/cyclin E and Cdc2/cyclin B1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903103833

MPF localization is controlled by nuclear export

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903103833

Control of cyclin B1 localization through regulated binding of the nuclear export factor CRM1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903103833

The human Myt1 kinase preferentially phosphorylates Cdc2 on threonine 14 and localizes to the endoplasmic reticulum and Golgi complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903103833

Inactivation of the p34cdc2-cyclin B complex by the human WEE1 tyrosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903103833

Cdc25M2 activation of cyclin-dependent kinases by dephosphorylation of threonine-14 and tyrosine-15

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903103833

High expression of cyclin B1 predicts a favorable outcome in patients with follicular lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903103833

Staurosporine-induced G2/M arrest in primary effusion lymphoma BCBL-1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903103833

Inhibition of CDK1 as a potential therapy for tumors over-expressing MYC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903103833

Inhibition of cyclin-dependent kinase-2 induces apoptosis in human diffuse large B-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903103833

ABT-263 and rapamycin act cooperatively to kill lymphoma cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903103833

The farnesyltransferase inhibitor L744832 potentiates UCN-01-induced apoptosis in human multiple myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903103833

Activation of the PI3K/Akt pathway and chemotherapeutic resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903103833

Interference with PDK1-Akt survival signaling pathway by UCN-01 (7-hydroxystaurosporine).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903103833

A p34(cdc2) survival checkpoint in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903103833

A phase 2 clinical trial of deforolimus (AP23573, MK-8669), a novel mammalian target of rapamycin inhibitor, in patients with relapsed or refractory hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903103833

Evidence That 3-Phosphoinositide-dependent Protein Kinase-1 Mediates Phosphorylation of p70 S6 Kinasein Vivoat Thr-412 as well as Thr-252

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903103833

p70s6k function is essential for G1 progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903103833

10.1517/14728220903103833

21 January 2018

Identifiers

DOI

1 reference

21 August 2017

1 reference

PubMed ID

19614561